Cancer research
Fresh data on prostate cancer research reveal that the RNA editing gene APOBEC3C has been identified as a potential candidate tumor suppressor. According to a study published in the journal Scientific Reports, the researchers investigated the role of APOBEC3C in prostate cancer (PCa) and found that it exhibits significant positive
Cancer research
A new study from Shandong University in China has provided insights into the role of traditional Chinese medicine (TCM) in improving lung cancer treatment. Researchers found that TCM compounds, such as cantharidin, boehmenan, shikonin, and salidroside, have potential in modulating the tumor microenvironment (TME) and enhancing conventional therapies. These compounds
Cancer research
New research has shed light on the potential benefits and costs of incorporating one-off upper abdominal CT screening as an add-on to lung cancer screening in England. The study, led by researchers at the University of Sheffield, aimed to assess the cost-effectiveness of this approach and its impact on various
Cancer research
Lung cancer is a leading cause of cancer-related deaths worldwide, with smoking being a significant risk factor. A recent study published in the journal Antioxidants has shed light on the relationship between serum creatinine, an endogenous antioxidant biomarker, and lung cancer risk in men smokers. The research, conducted by a
Cancer research
A new study conducted at Fujian Medical University Union Hospital in Fuzhou, People's Republic of China, has evaluated the prognostic impact of methylation-related gene mutations in older patients with acute myeloid leukemia (AML). The research analyzed clinical characteristics in 645 patients aged 60 years diagnosed with AML between
Cancer research
Researchers at Lanzhou University have made a groundbreaking discovery in the field of colon cancer, identifying five longevity-associated genes (LAGs) that can be used to predict treatment outcomes for patients. According to the study, published in the journal Biomedicines, the five LAGs - BEDN3, EXOC3L2, CDKN2A, IL-13, and CAPN9 -
Cancer research
New research from the Princess Margaret Cancer Centre in Toronto, Canada, has shed light on the role of somatic mutations in epigenetic modifier genes and activated signaling/myeloid transcription factors (AS/MTFs) in chronic myeloid leukemia (CML) treatment outcomes. The study found that mutations in AS/MTF genes independently serve
Cancer research
Research conducted by the University of Texas MD Anderson Cancer Center has shed new light on the epigenetic determinants driving bone metastasis in cancer patients. The study, funded by the U.S. Department of Health & Human Services, the Prostate Cancer Foundation, the Cancer Prevention And Research Institute of Texas,
Cancer research
A new research study, conducted by a team at Yonsei University, presents a significant advancement in the diagnosis of brain cancer through the development of a Convolutional Neural Network (CNN) model dubbed MediAI. This AI-powered method leverages transfer learning with ResNet50 to classify MRI images of primary brain tumors, achieving
Cancer research
Researchers from the University of California San Francisco (UCSF) have analyzed inpatient clinical notes to understand how documentation around palliative care has changed in relation to metastatic cancer. Using unsupervised language models, the team found that while metastatic cancer and palliative care terms were initially used together in similar contexts,
Cancer research
A recent study has shed new light on the characteristics of patients with high-risk biochemical recurrence (BCR) of prostate cancer, providing valuable insights for improved treatment strategies. The research, conducted by a team of experts from Northwestern University, analyzed the PET/CT findings of 145 patients with high-risk BCR after
Cancer research
Researchers have made a groundbreaking discovery in the field of oncology, specifically in the detection of prostate cancer metastasis using circulating tumor DNA (ctDNA). According to a study published in The Oncologist, Investigators from the University of Foggia in Italy have found that ctDNA acts as an early biomarker of
